SCHEMBL19783284

SCHEMBL19783284

Cc1cc(-c2cc3ccccc3o2)c2ncc(CO)nc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 4/20 0.62
TOP2A P11388 1/20 0.39
PDE4D Q08499 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
KMT2A Q03164 4/20 0.38
POLB P06746 3/20 0.38
MEN1 O00255 3/20 0.37
ALDH1A1 P00352 2/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP3A4 P08684 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189642 1.00 F2RL3 (0.62) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL30187684 0.89 F2RL3 (0.63) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL19783470 0.89 F2RL3 (0.63) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL30187605 0.87 F2RL3 (0.64) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL19783398 0.87 F2RL3 (0.64) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL30189637 0.81 F2RL3 (0.61) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL19783803 0.81 F2RL3 (0.73) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL30189755 0.81 F2RL3 (0.64) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL19782922 0.81 F2RL3 (0.64) F2RL3TOP2APDE4DMAOAMAOB
SCHEMBL30187691 0.81 F2RL3 (0.73) F2RL3TOP2APDE4DMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 F2RL3 2/4885TOP2A 2114/4885PDE4D 497/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 F2RL3 2/4885TOP2A 2315/4885PDE4D 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.